Test-retest repeatability of ADC in prostate using the multi b-value VERDICT acquisition Journal Article


Authors: Rogers, H. J.; Singh, S.; Barnes, A.; Obuchowski, N. A.; Margolis, D. J.; Malyarenko, D. I.; Chenevert, T. L.; Shukla-Dave, A.; Boss, M. A.; Punwani, S.
Article Title: Test-retest repeatability of ADC in prostate using the multi b-value VERDICT acquisition
Abstract: Purpose: VERDICT (Vascular, Extracellular, Restricted Diffusion for Cytometry in Tumours) MRI is a multi b-value, variable diffusion time DWI sequence that allows generation of ADC maps from different b-value and diffusion time combinations. The aim was to assess precision of prostate ADC measurements from varying b-value combinations using VERDICT and determine which protocol provides the most repeatable ADC. Materials and Methods: Forty-one men (median age: 67.7 years) from a prior prospective VERDICT study (April 2016–October 2017) were analysed retrospectively. Men who were suspected of prostate cancer and scanned twice using VERDICT were included. ADC maps were formed using 5b-value combinations and the within-subject standard deviations (wSD) were calculated per ADC map. Three anatomical locations were analysed per subject: normal TZ (transition zone), normal PZ (peripheral zone), and index lesions. Repeated measures ANOVAs showed which b-value range had the lowest wSD, Spearman correlation and generalized linear model regression analysis determined whether wSD was related to ADC magnitude and ROI size. Results: The mean lesion ADC for b0 b1500 had the lowest wSD in most zones (0.18–0.58x10-4 mm2/s). The wSD was unaffected by ADC magnitude (Lesion: p = 0.064, TZ: p = 0.368, PZ: p = 0.072) and lesion Likert score (p = 0.95). wSD showed a decrease with ROI size pooled over zones (p = 0.019, adjusted regression coefficient = -1.6x10-3, larger ROIs for TZ versus PZ versus lesions). ADC maps formed with a maximum b-value of 500 s/mm2 had the largest wSDs (1.90–10.24x10-4 mm2/s). Conclusion: ADC maps generated from b0 b1500 have better repeatability in normal TZ, normal PZ, and index lesions. © 2023 The Authors
Keywords: aged; retrospective studies; magnetic resonance imaging; prospective study; prospective studies; pathology; diagnostic imaging; retrospective study; prostate cancer; prostatic neoplasms; prostate; prostate tumor; diffusion weighted imaging; diffusion magnetic resonance imaging; repeatability; procedures; apparent diffusion coefficient; humans; human; male
Journal Title: European Journal of Radiology
Volume: 162
ISSN: 0720-048X
Publisher: Elsevier B.V  
Date Published: 2023-05-01
Start Page: 110782
Language: English
DOI: 10.1016/j.ejrad.2023.110782
PUBMED: 37004362
PROVIDER: scopus
PMCID: PMC10334409
DOI/URL:
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- Export Date: 1 May 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Amita Dave
    138 Dave